Literature DB >> 10794555

Chondromyxoid fibroma of the acromium with soft tissue extension.

D Macdonald1, V Fornasier, R Holtby.   

Abstract

Chondromyxoid fibroma is an unusual, benign tumor of cartilaginous origin and represents less than 1% of all primary bone tumors. It usually involves the long bones around the knee joint or the flat bones of the pelvis or ribs. Soft tissue extension is also thought to be rare in these lesions. They are usually eccentrically located in the metaphyses of the long bones and centrally in the flat bones. The radiographic appearances are characteristically those of a single, lytic lesion with lobulated margins, septations, cortical expansion and a sclerotic rim. Histologically, they display a lobulated pattern with spindle-shaped cells lying within a myxoid matrix with areas of hyaline cartilage. The differential diagnosis includes giant cell tumor, chondroblastoma or enchondroma as well as chondrosarcoma. The rarity of these lesions may render the diagnosis difficult to make, especially when the lesion involves an unusual site such as the acromium.

Entities:  

Mesh:

Year:  2000        PMID: 10794555     DOI: 10.1007/s002560050588

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  3 in total

Review 1.  The imaging of cartilaginous bone tumours. I. Benign lesions.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-17       Impact factor: 2.199

2.  Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites.

Authors:  Henry B Armah; Richard L McGough; Mark A Goodman; Susanne M Gollin; Urvashi Surti; Anil V Parwani; Uma N M Rao
Journal:  Diagn Pathol       Date:  2007-11-24       Impact factor: 2.644

3.  A rare case of chondroblastoma of the acromion.

Authors:  Murat Arıkan; Güray Toğral; Ahmet Yıldırım; Çiğdem Irkkan
Journal:  Acta Orthop Traumatol Turc       Date:  2016-12-10       Impact factor: 1.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.